Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Investors with deep China roots lead NewCo surge, inspiring Western VCs

Led by Orbimed, LAV, Boyu, biotech’s Asia ‘NewCo Model’ goes global

February 1, 2025 2:58 AM UTC

In the race to capitalize on Asia’s “NewCo Model,” a pair of investors with deep roots in China have been the most active since the trend began four years ago. The concept has now gone global, with more than 50 other investors from outside of Asia drawn by the rapid rate and high quality of innovation they can find there, including top firms from Europe and the U.S. 

BioCentury has identified 13 companies that were launched in the West based on assets sourced in Asia, and more are clearly in the works if conversations at this year’s J.P. Morgan Healthcare Conference are anything to go on. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article